BI Logo 395 5/2.5 Pill - gray elliptical/oval
Generic Name: empagliflozin/linagliptin/metformin
Pill with imprint BI Logo 395 5/2.5 is Gray, Elliptical/Oval and has been identified as Trijardy XR empagliflozin 5 mg / linagliptin 2.5 mg / metformin hydrochloride 1000 mg extended-release. It is supplied by Boehringer Ingelheim and Eli Lilly and Company.
Trijardy XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Trijardy XR empagliflozin 5 mg / linagliptin 2.5 mg / metformin hydrochloride 1000 mg extended-release is not a controlled substance under the Controlled Substances Act (CSA).
Images for BI Logo 395 5/2.5
Trijardy XR
- Generic Name
- empagliflozin/linagliptin/metformin
- Imprint
- BI Logo 395 5/2.5
- Strength
- empagliflozin 5 mg / linagliptin 2.5 mg / metformin hydrochloride 1000 mg extended-release
- Color
- Gray
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Boehringer Ingelheim and Eli Lilly and Company
- National Drug Code (NDC)
- 00597-0395
More about Trijardy XR (empagliflozin / linagliptin / metformin)
- Check interactions
- Pricing & coupons
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
